A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naĆÆve Subjects Not Part of H03_01TP Study
PHASE1
GVGH Shigella Sonnei 1970GAHB is a vaccine aimed at preventing the disease ...
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
PHASE1
This is a first-in-human (Phase 1) and Phase 2 study of a single vaccinatio...
Study on Immunogenicity, Reactogenicity and Safety of the VACĪ6 Vaccine in Volunteers Aged 18-60 Years
PHASE2
The Aim:
Study immunogenicity, confirm the safety and tolerability of diff...
Status
Completed
Location
Federal State Budgetary Institution of Healthcare "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency" (FGBUZ MSCH-163, FMBA of Russia)
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...
PHASE1
Background:
Malaria remains a major global health problem. Malaria is spre...